Cargando…
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia
Identifying novel drug targets to overcome resistance to tyrosine kinase inhibitors (TKIs) and eradicating leukemia stem/progenitor cells are required for the treatment of chronic myelogenous leukemia (CML). Here, we show that ubiquitin-specific peptidase 47 (USP47) is a potential target to overcome...
Autores principales: | Lei, Hu, Xu, Han-Zhang, Shan, Hui-Zhuang, Liu, Meng, Lu, Ying, Fang, Zhi-Xiao, Jin, Jin, Jing, Bo, Xiao, Xin-Hua, Gao, Shen-Meng, Gao, Feng-Hou, Xia, Li, Yang, Li, Liu, Li-Gen, Wang, Wei-Wei, Liu, Chuan-Xu, Tong, Yin, Wu, Yun-Zhao, Zheng, Jun-Ke, Chen, Guo-Qiang, Zhou, Li, Wu, Ying-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782553/ https://www.ncbi.nlm.nih.gov/pubmed/33397955 http://dx.doi.org/10.1038/s41467-020-20259-0 |
Ejemplares similares
-
Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
por: Xu, Zhenshu, et al.
Publicado: (2009) -
A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors
por: Li, Qing, et al.
Publicado: (2016) -
Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
por: Ji, Qing, et al.
Publicado: (2016) -
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis
por: Jiang, Shuoyi, et al.
Publicado: (2021) -
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
por: Shan, Huizhuang, et al.
Publicado: (2018)